A detailed history of Perceptive Advisors LLC transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Perceptive Advisors LLC holds 543,277 shares of DYN stock, worth $6.46 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares
543,277
Previous 718,144 24.35%
Holding current value
$6.46 Million
Previous $25.8 Million 50.38%
% of portfolio
0.43%
Previous 0.67%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

SELL
$23.56 - $35.55 $4.12 Million - $6.22 Million
-174,867 Reduced 24.35%
543,277 $12.8 Million
Q3 2024

Nov 14, 2024

BUY
$31.94 - $47.04 $22.9 Million - $33.8 Million
718,144 New
718,144 $25.8 Million
Q1 2021

May 17, 2021

SELL
$14.0 - $29.3 $5.6 Million - $11.7 Million
-400,000 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$20.0 - $23.9 $8 Million - $9.56 Million
400,000 New
400,000 $8.08 Million

Others Institutions Holding DYN

About Dyne Therapeutics, Inc.


  • Ticker DYN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,765,400
  • Market Cap $615M
  • Description
  • Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...
More about DYN
Track This Portfolio

Track Perceptive Advisors LLC Portfolio

Follow Perceptive Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perceptive Advisors LLC with notifications on news.